<html><head></head><body><h1>Naphazoline</h1><p class="drug-subtitle"><b>Generic Name:</b> Naphazoline hydrochloride<br/>
<b>Dosage Form:</b> ophthalmic solution<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Professional</li>
<li>Interactions</li>
<li>Reviews</li>
<li>Compare</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Patient Counseling Information</li>
<li class="ddc-toggle-hidden">Drug Interactions</li>
<li class="ddc-toggle-hidden">Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx only</span></p><h2>DESCRIPTION:</h2><p class="First">Naphazoline Hydrochloride, an ocular vasoconstrictor, is an imidazoline derivative sympathomimetic amine. It occurs as a white, odorless crystalline powder having a bitter taste and is freely soluble in water and in alcohol. The active ingredient is represented by the structural formula:</p><p><span class="Bold">Chemical Name:</span></p><p>2-(1-naphthylmethyl)-2-imidazole monohydrochloride</p><p><span class="Bold">Each mL contains:</span></p><p><span class="Bold">Active:</span> Naphazoline Hydrochloride 1 mg (0.1%).</p><p><span class="Bold">Inactives:</span> Boric Acid, Edetate Disodium, Sodium Carbonate, Sodium Chloride and Hydrochloric Acid may be added to adjust pH (5.5 to 7.0), and Water for Injection.</p><p><span class="Bold">Preservative:</span> Benzalkonium Chloride 0.1 mg (0.01%). Naphazoline Hydrochloride Ophthalmic Solution, USP, 0.1% is a sterile solution with a pH between 5.5 and 7.0.</p><h2>CLINICAL PHARMACOLOGY:</h2><p class="First">Naphazoline constricts the vascular system of the conjunctiva. It is presumed that this effect is due to direct stimulation of the drug upon the alpha adrenergic receptors in the arterioles of the conjunctiva resulting in decreased conjunctival congestion. Naphazoline belongs to the imidazoline class of sympathomimetics.</p><h2>INDICATIONS AND USAGE:</h2><p class="First">Naphazoline Hydrochloride Ophthalmic Solution is indicated for use as a topical ocular vasoconstrictor.</p><h2>CONTRAINDICATIONS:</h2><p class="First">Contraindicated in the presence of an anatomically narrow angle or in narrow angle glaucoma or in persons who have shown hypersensitivity to any component of this preparation.</p><h2>WARNINGS:</h2><p class="First">Patients under therapy with MAO inhibitors may experience a severe hypertensive crisis if given a sympathomimetic drug. Use in children, especially infants, may result in CNS depression leading to coma and marked reduction in body temperature.</p><h2>PRECAUTIONS:</h2><p class="First"><span class="Bold">General:</span> For topical ophthalmic use only. Use with caution in presence of hypertension, cardiovascular abnormalities, hyperglycemia (diabetes), hyperthyroidism, infection or injury.</p><p class="First"><span class="Bold">Patient Information:</span> Patients should be advised to discontinue the drug and consult the physician if relief is not obtained within 48 hours of therapy, if irritation, blurring or redness persists or increases, or if symptoms of systemic absorption occur, i.e., dizziness, headache, nausea, decrease in body temperature, or drowsiness.</p><p>To prevent contaminating the dropper tip and solution, do not touch any surface, the eyelids or the surrounding area with the dropper tip of the bottle. If solution changes color or becomes cloudy, do not use.</p><p class="First"><span class="Bold">Drug Interactions:</span> Concurrent use of maprotiline or tricyclic antidepressants and Naphazoline may also potentiate the pressor effect of Naphazoline. Patients under therapy with MAO inhibitors may experience a severe hypertensive crisis if given a sympathomimetic drug. (See WARNINGS).</p><h3>Pregnancy:</h3><p class="First"><span class="Bold">Pregnancy Category C:</span> Animal reproduction studies have not been conducted with Naphazoline. It is also not known whether Naphazoline can cause harm when administered to a pregnant women or can affect reproduction capacity. Naphazoline should be given to a pregnant women only if clearly needed.</p><p class="First"><span class="Bold">Nursing Mothers:</span> It is not known whether Naphazoline is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Naphazoline is administered to a nursing women.</p><p class="First"><span class="Bold">Pediatric Use:</span> Safety and effectiveness in the pediatric population have not been established. See “WARNINGS” and “CONTRAINDICATIONS”.</p><h2>ADVERSE REACTIONS:</h2><p class="First"><span class="Bold">Ocular:</span> Mydriasis, increased redness, irritation, discomfort, blurring, punctate keratitis, lacrimation, increased intraocular pressure.</p><p class="First"><span class="Bold">Systemic:</span> Dizziness, headache, nausea, sweating, nervousness, drowsiness, weakness, hypertension, cardiac irregularities, and hyperglycemia.</p><h2>DOSAGE AND ADMINISTRATION:</h2><p class="First">Instill one or two drops in the conjunctival sac(s) every three to four hours as needed.</p><h2>HOW SUPPLIED:</h2><p class="First">Naphazoline Hydrochloride Ophthalmic Solution, USP, is supplied as a sterile 0.1% solution in 15 mL plastic dropper bottles. NDC 17478-216-12</p><p class="First"><span class="Bold">Storage:</span> Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].</p><p>Keep container tightly closed.</p><p><span class="Bold">Akorn</span></p><p>Manufactured by: <span class="Bold">Akorn, Inc.</span></p><p>Lake Forest, IL 60045</p><p>GNH00N Rev. 10/16</p><p class="First">Principal Display Panel Text for Container Label:</p><p>NDC 17478-216-12</p><p>Naphazoline</p><p>Hydrochloride</p><p>Ophthalmic</p><p>Solution, USP</p><p>0.1%</p><p>15 mL</p><p>Sterile</p><p>Rx only</p><p class="First">Principal Display Panel Text for Carton Label:</p><p>NDC 17478-216-12</p><p>Naphazoline</p><p>Hydrochloride</p><p>Ophthalmic</p><p>Solution, USP</p><p>0.1%</p><p>15 mL</p><p>Sterile</p><p>Rx only Akorn Logo</p><h2>More about naphazoline ophthalmic</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: ophthalmic antihistamines and decongestants</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Naphazoline Ophthalmic &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Naphazoline (Ophthalmic) &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Eye Redness</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>